| Literature DB >> 36005261 |
Trung Quoc Hieu Huynh1, Thi Lan Anh Pham2, Van Tam Vo2, Ha Ngoc The Than3, Tan Van Nguyen3.
Abstract
BACKGROUND: Frailty syndrome is common among older people and can lead to various adverse consequences such as falls, cognitive decline, disability, dependent living, increased mortality, excessive drug use, and prolonged hospital stays.Entities:
Keywords: Vietnam; aging; community; frailty; functional decline; older adults
Year: 2022 PMID: 36005261 PMCID: PMC9407721 DOI: 10.3390/geriatrics7040085
Source DB: PubMed Journal: Geriatrics (Basel) ISSN: 2308-3417
Participant characteristics (n = 584).
| Participants’ Characteristics | |
|---|---|
| Sex | |
| Male | 175 (30) |
| Female | 409 (70) |
| Age 69.57 ± 7.25 (60–92) * | |
| 60–69 years old | 321 (55) |
| 70–79 years old | 200 (34.3) |
| 80 years or older | 63 (10.7) |
| Living situation | |
| Alone | 150 (25.7) |
| With relatives | 434 (74.3) |
| BMI levels | |
| Underweight (<18.5 kg/m2) | 49 (8.4) |
| Normal (18.5–22.9 kg/m2) | 242 (41.4) |
| Overweight (23–24.9 kg/m2) | 117 (20) |
| Obese (>25 kg/m2) | 176 (30.1) |
| Current smoking | |
| Yes | 53 (9.1) |
| No | 531 (90.92) |
| Sarcopenia | |
| Non-sarcopenia | 271 (46.4) |
| Sarcopenia | 284 (48.6) |
| Severe sarcopenia | 29 (5) |
| Comorbidity | |
| Hypertension | 306 (52.4) |
| Dyslipidemia | 217 (37.2) |
| Diabetes | 105 (18) |
| Chronic kidney disease | 38 (6.5) |
| Charlson Comorbidity Index | |
| 0 point | 177 (30.3) |
| 1–2 points | 279 (47.8) |
| ≥3 points | 128 (21.9) |
| Polypharmacy (≥5 drugs) | 74 (12.67) |
* Mean ± standard deviation (minimum-maximum).
Prevalence of frailty status and components (n = 584).
| Characteristics | Frailty Status | ||||
|---|---|---|---|---|---|
|
| % | Robust | Pre-Frail | Frail | |
| Frailty status | 584 | 100 | 99 (17) | 374 (64) | 111 (19) |
| Slowness | 211 | 36.1 | |||
| Weakness | 373 | 63.9 | |||
| Low physical activity | 114 | 19.5 | |||
| Exhaustion | 108 | 18.5 | |||
| Weight loss | 126 | 21.6 | |||
Association between frailty status and study sample characteristics (n = 584).
| Participants’ Characteristics | Frailty Status | Bivariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|---|---|
| Frail | Non-Frail | OR | 95% CI |
| aOR | 95% aCI | aP | |
| Sex | ||||||||
| Male | 27 (15.4) | 148 (84.6) | 0.71 | (0.44–1.14) | 0.151 | 0.66 | (0.40–1.10) | 0.110 |
| Female | 84 (20.5) | 325 (79.5) | Ref | Ref | ||||
| Age | ||||||||
| 60–69 years old | 50 (15.6) | 271 (84.4) | Ref | Ref | ||||
| 70–79 years old | 40 (20.0) | 160 (80.0) | 1.36 | (0.86–2.15) | 0.195 | 1.09 | (0.67–1.77) | 0.730 |
| 80 years or older | 21 (33.3) | 42 (66.7) | 2.71 | (1.48–4.96) | 0.001 | 2.04 | (1.07–3.91) | 0.032 |
| Living situation | ||||||||
| Alone | 40 (26.7) | 110 (73.3) | 1.86 | (1.19–2.89) | 0.006 | 1.64 | (1.04–2.61) | 0.035 |
| With relatives | 71 (16.4) | 363 (83.6) | Ref | Ref | ||||
| BMI levels | ||||||||
| Underweight (<18.5 kg/m2) | 16 (32.7) | 33 (67.3) | 2.24 | (1.13–4.440) | 0.020 | 2.21 | (1.06–4.6) | 0.034 |
| Normal weight (18.5–22.9 kg/m2) | 43 (17.8) | 199 (82.2) | Ref | Ref | ||||
| Overweight (23–24.9 kg/m2) | 22 (18.8) | 95 (81.2) | 1.07 | (0.61–1.89) | 0.811 | 1.22 | (0.67–2.22) | 0.516 |
| Obese (≥25 kg/m2) | 30 (17.1) | 146 (82.9) | 0.95 | (0.57–1.59) | 0.848 | 1.18 | (0.67–2.09) | 0.565 |
| Current smoking | ||||||||
| Yes | 6 (11.3) | 47 (88.7) | 0.52 | (0.22–1.24) | 0.141 | |||
| No | 105 (19.8) | 426 (80.2) | Ref | |||||
| Sarcopenia | ||||||||
| Non-sarcopenia | 36 (13.3) | 235 (86.7) | Ref | Ref | ||||
| Sarcopenia | 71 (25.) | 213 (75) | 2.18 | (1.40–3.38) | 0.001 | 1.93 | (1.17–3.19) | 0.010 |
| Severe sarcopenia | 4 (13.8) | 25 (86.2) | 1.04 | (0.34–3.18) | 0.939 | 1.10 | (0.34–3.56) | 0.876 |
| Charlson Comorbidity Index | ||||||||
| 0 point | 30 (17) | 147 (83) | Ref | |||||
| 1–2 points | 44 (15.8) | 235 (84.2) | 0.92 | (0.55–1.52) | 0.043 | 0.87 | (0.51–147) | 0.598 |
| ≥3 points | 37 (28.9) | 91 (71.1) | 1.99 | (1.15–3.45) | 0.014 | 1.73 | (0.95–3.16) | 0.074 |
| Polypharmacy (≥5 drugs) | ||||||||
| Yes | 20 (27) | 54 (73.0) | 1.71 | (0.97–2.99) | 0.062 | |||
| No | 91 (17.8) | 419 (82.2) | Ref | |||||